News
5h
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine DisputeGlaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street ...
9h
TipRanks on MSNGSK Enhances Shareholder Value with Strategic BuybackGlaxoSmithKline ( ($GB:GSK) ) just unveiled an announcement. GSK plc has announced the purchase of 494,426 of its own ordinary shares as part of ...
The market for IBAT inhibitors is projected to experience significant growth in the near future, fueled by the rising incidence of genetic disorders, a strong pipeline of clinical trials, and ...
Some FTSE 100 CEOs may have their pay climb even higher. For example, Emma Walmsley, boss at pharmaceutical giant ...
GSK’s share price is still significantly down on the year, despite very robust H1 results, leaving it looking extremely ...
London: GSK plc has announced that a supplemental New Drug Application for gepotidacin has been accepted by the US Food and ...
The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...
US FDA accepts for priority review GSK’s sNDA for gepotidacin for oral treatment of uncomplicated urogenital gonorrhoea: London, UK Tuesday, August 12, 2025, 10:00 Hrs [IST] GSK ...
Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results